Jefferies issues Buy ratings on Polycab, Torrent Pharma, and Ambuja Cements with up to 22% return potential - see if these stocks fit your portfolio!

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $452.16, moving +1.56% from the previous trading session. This change outpaced the S&P 500's 0.11% loss on the day. Meanwhile, the ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli Lilly ...

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB Pharma from global investment firm KKR at ...

Gujarat-based pharma giant announces acquisition of rival JB Chemicals and Pharmaceuticals stake for ₹11,917 crore in first phase ...

The market for weight management medicines has been the hottest therapeutic area in the past two years. The pharmaceutical giant has far too much going its way. Analysts predict that the weight ...

Water-Cooled Systems Drive 4.4% CAGR Growth as Process Cooling Demand Surges Across Chemical, Pharmaceutical, and Manufacturing Industries Worldwide REDDING, Calif., June 27, 2025 /PRNewswire/ ...

Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...